Skip to main content
Premium Trial:

Request an Annual Quote

Catherine Ball

Ancestry has appointed Catherine Ball as Chief Scientific Officer. The consumer genomics firm promoted her from VP of Genomics and Bioinformatics, a job she's held since 2011. 

As CSO, Ball will lead initiatives to develop new technologies to analyze genetic data along with family relationship data.

Prior to joining Ancestry, Ball held appointments at the Stanford University School of Medicine in the Departments of Genetics and Biochemistry, where she led the Stanford Microarray Database. As part of her research, she contributed to the annotation of the Saccharomyces cerevisiae genome and has built genomic databases for yeast, Escherichia coli, and Mycobacterium tuberculosis.

Ball holds a doctorate in molecular biology from the University of California, Los Angeles and she was a postdoc at UC-Berkeley.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.